Michael Jablonski, PhD

Dr Jablonski is the vice president of Clinical Development and Medical Affairs, Mental Health at Boehringer Ingelheim.

Articles by Michael Jablonski, PhD

An Exciting Time for Schizophrenia Research

ByMichael Jablonski, PhD

October 2nd 2024

The vice president of Clinical Development and Medical Affairs, Mental Health at Boehringer Ingelheim shares why it is such an unprecedented moment for schizophrenia research.

Michael Jablonski, PhD

Articles by Michael Jablonski, PhD

An Exciting Time for Schizophrenia Research

Latest Updated Articles

Trending on Psychiatric Times

Recognizing the Neuropsychiatric Symptoms of Huntington Disease

New ECNP Poster Data on Adjunctive Lumateperone for Major Depressive Disorder

"The Harvest"

Trust, Compassion, and Care: A World Mental Health Day Reflection

Poll: How Can We Individually and Collectively Improve Our Mental Health?